Authors : Yamini Rawate, Priyanka Patel
DOI : 10.18231/j.ijceo.2022.097
Volume : 8
Issue : 4
Year : 2022
Page No : 481-486
Purpose: To analyze different ophthalmic manifestations of rhino-orbital mucormycosis (ROM) infection in COVID-19 patients.
Study Design: Prospective interventional clinical study.
Materials and Methods: 20 microbiologically confirmed ROCM cases with ophthalmic involvement hospitalized between May 2021 and July 2021 in our center were included in this study.
Results: Among 20 cases there were 9 females and 11 males with a mean age of 57.5?years. All 20 patients had uncontrolled type 2 diabetes with a mean diagnosis duration of 3.67 years. All patients had COVID-19-associated acute respiratory distress syndrome and received corticosteroids. The mean time interval between COVID-19 diagnosis and ROM diagnosis was 3.46 days. 4 patients (20%) had orbital apex syndrome, and 16 patients (80%) presented with orbital cellulitis. CT scan/MRI revealed sino-orbital involvement in all patients, and 3 of these had cerebral involvement at initial presentation. All 20 patients received intravenous amphotericin B and 7 patients received TRAMB and all 20 patients had undergone radical debridement of involved sinuses. Despite all measures, 3 (7.5%) of 20 patients with cerebral dissemination expired.
Conclusions: Severe COVID-19 is associated with a significant incidence of ROM with higher mortality rates due to immune dysregulation and the widespread use of steroids. An aggressive multidisciplinary approach can help to reduce mortality.
Keywords: Rhinoorbitalcerebralmucormycosis (ROCM), Orbital apex syndrome, Orbital cellulitis, Transcutaneous retrobulbar liposomal amphotericin B (TRAMB).